- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy ; volume:7 ; number:1 ; day:10 ; month:7 ; year:2019 ; pages:1-7 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (10.7.2019), 1-7, 12.2019
- Urheber
-
Dama, Paola
Tang, Marshall
Fulton, Noreen
Kline, Justin
Liu, Hongtao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0611-3
- URN
-
urn:nbn:de:101:1-2019112211303369701255
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dama, Paola
- Tang, Marshall
- Fulton, Noreen
- Kline, Justin
- Liu, Hongtao
- SpringerLink (Online service)
Ähnliche Objekte (12)
FAiL | twice! | fail
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy
AML
AML
AML
AML
"AML!
Early changes in gene expression profiles in AML patients during induction chemotherapy
Prof. Fail
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
EASt AML
Aml Ameen
FAiL | twice! | fail
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy
AML
AML
AML
AML
"AML!
Early changes in gene expression profiles in AML patients during induction chemotherapy
Prof. Fail
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
EASt AML
Aml Ameen
FAiL | twice! | fail
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy
AML
AML
AML
AML
"AML!
Early changes in gene expression profiles in AML patients during induction chemotherapy
Prof. Fail
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
EASt AML